Arno Hänninen

Arno Hänninen

Auto-generated profile, based on publicly available information

Arno Hänninen

Department of Clinical Microbiology and Immunology, Turku University Hospital, Turku, Finland

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2017 in Gut
Verified
Journal Article
Closed access
PDF file
AHArno Hänninen
Arno Hänninen
RTRaine Toivonen
Raine Toivonen
SPSakari Pöysti
Sakari Pöysti
CBClara Belzer
Clara Belzer
HPHubert Plovier
Hubert Plovier
WVWillem M De Vos
Willem M De Vos
Objective: Intestinal microbiota is implicated in the pathogenesis of autoimmune type 1 diabetes in humans and in non-obese diabetic (NOD) mice, but evidence on its causality and on the role of individual microbiota members is limited. We investigated if different diabetes incidence in two NOD colonies was due to microbiota differences and aimed to identify individual microbiota members with potential significance. Design: We profiled intestinal microbiota between two NOD mouse colonies showing high or low diabetes incidence by 16S ribosomal RNA gene sequencing and colonised the high-incidence colony with the microbiota of the low-incidence colony. Based on unaltered incidence, we identified a few taxa which were not effectively transferred and thereafter, transferred experimentally one of these to test its potential significance. Results: Although the high-incidence colony adopted most microbial taxa present in the low-incidence colony, diabetes incidence remained unaltered. Among the few taxa which were not transferred, Akkermansia muciniphila was identified. As A. muciniphila abundancy is inversely correlated to the risk of developing type 1 diabetes-related autoantibodies, we transferred A. muciniphila experimentally to the high-incidence colony. A. muciniphila transfer promoted mucus production and increased expression of antimicrobial peptide Reg3γ , outcompeted Ruminococcus torques from the microbiota, lowered serum endotoxin levels and islet toll-like receptor expression, promoted regulatory immunity and delayed diabetes development. Conclusion: Transfer of the whole microbiota may not reduce diabetes incidence despite a major change in gut microbiota, but single symbionts such as A. muciniphila with beneficial metabolic and immune signalling effects may reduce diabetes incidence when administered as a probiotic.

4 April 2017 in The ISME Journal
Verified
Journal Article
Closed access
EMEveliina Munukka
Eveliina Munukka
ARAnniina Rintala
Anniina Rintala
RTRaine Toivonen
Raine Toivonen
MNMatts Nylund
Matts Nylund
Baoru YangBaoru Yang
Baoru Yang
Satu PekkalaSatu Pekkala
Satu Pekkala
Faecalibacterium prausnitzii is considered as one of the most important bacterial indicators of a healthy gut. We studied the effects of oral F. prausnitzii treatment on high-fat fed mice. Compared to the high-fat control mice, F. prausnitzii-treated mice had lower hepatic fat content, aspartate aminotransferase and alanine aminotransferase, and increased fatty acid oxidation and adiponectin signaling in liver. Hepatic lipidomic analyses revealed decreases in several species of triacylglycerols, phospholipids and cholesteryl esters. Adiponectin expression was increased in the visceral adipose tissue, and the subcutaneous and visceral adipose tissues were more insulin sensitive and less inflamed in F. prausnitzii-treated mice. Further, F. prausnitzii treatment increased muscle mass that may be linked to enhanced mitochondrial respiration, modified gut microbiota composition and improved intestinal integrity. Our findings show that F. prausnitzii treatment improves hepatic health, and decreases adipose tissue inflammation in mice and warrant the need for further studies to discover its therapeutic potential.

22 January 2015 in Blood
Verified
Journal Article
Open access
PDF file
EHEmma M. Haapaniemi
Emma M. Haapaniemi
MKMeri Kaustio
Meri Kaustio
HRHanna L. M. Rajala
Hanna L. M. Rajala
AAArjan J. van Adrichem
Arjan J. van Adrichem
LKLeena Kainulainen
Leena Kainulainen
JKJuha Kere
Juha Kere
Key Points: Germline activating STAT3 mutations were detected in 3 patients with autoimmunity, hypogammaglobulinemia, and mycobacterial disease. T-cell lymphoproliferation, deficiency of regulatory and helper 17 T cells, natural killer cells, dendritic cells, and eosinophils were common.

5 March 2011 in Diabetologia
Verified
Journal Article
Open access
PDF file
CAC. Alam
C. Alam
EBE. Bittoun
E. Bittoun
DBD. Bhagwat
D. Bhagwat
SVS. Valkonen
S. Valkonen
ASA. Saari
A. Saari
AHA. Hänninen
A. Hänninen
Aims/hypothesis Microbial factors influence the development of diabetes in NOD mice. Studies in germ-free animals have revealed important roles of microbiota in the regulation of Th17 and forkhead box P3 (FOXP3)+ T regulatory (Treg) activation in the intestine. However, the effects of intestinal microbiota in immune regulation and diabetes development in NOD mice are still poorly understood. Methods A colony of germ-free NOD mice was established to evaluate the effects of intestinal microbiota on regulatory immunity in the gut, and on the development of insulitis and diabetes in NOD mice. Results Diabetes developed in roughly equal numbers in germ-free and specific pathogen-free NOD mice. Insulitis was accentuated in germ-free NOD mice; yet insulin preservation was unaltered. Germ-free NOD mice showed increased levels of Il17 (also known as Il17a) mRNA in the colon, and of Th17 and Th1 cells in the mesenteric and pancreatic lymph nodes, while Foxp3 mRNA and FOXP3+ Tregs were reduced. In the islet infiltrates, FOXP3+CD4+ T cells were slightly increased in germ-free mice. B cells appeared less activated in the peritoneum and were less abundant in islet infiltrates. Conclusions/interpretation These results indicate that lack of intestinal microbiota promotes an imbalance between Th1, Th17 and Treg differentiation in the intestine. This imbalance is associated with accelerated insulitis, but intact recruitment of FOXP3+ Tregs into islets, suggesting: (1) a microbial dependence of local induction of Treg in the gut and draining lymph nodes; but (2) a potentially compensatory function of naturally occurring Tregs in the islets, which may help control diabetogenic T cells.

4 January 2011 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
AHArno Hänninen
Arno Hänninen
MMMikael Maksimow
Mikael Maksimow
CACatharina Alam
Catharina Alam
DMDavid J. Morgan
David J. Morgan
SJSirpa Jalkanen
Sirpa Jalkanen
Ly6C is a murine cell‐surface antigen expressed by plasma cells, subsets of myeloid cells and many T cells, including memory T cells. We previously documented that Ly6C crosslinking induces LFA‐1 clustering on naïve CD8+ T cells. Here, we show that in vitro and in vivo differentiation of naïve CD8+ T cells into central (Tcm) but not effector (Tem) memory T cells enhances Ly6C expression, and its crosslinking induces strong LFA‐1 clustering on Tcm. Blocking Ly6C function inhibits in vivo Tcm homing to LNs as efficiently as blocking L‐selectin but it does not potentiate the inhibition provided by blocking either L‐selectin or LFA‐1 function. Thus, Ly6C, L‐selectin and LFA‐1 all appear to be part of a common homing pathway. In vitro, Ly6C crosslinking enhances Tcm adherence to ICAM‐1 in the presence of CCL21. In summary, Tcm homing involves Ly6C, in addition to L‐selectin and LFA‐1, and appears to potentiate firm adhesion of Tcm to ICAM‐1 in synergy with a chemokine. We propose that Ly6C augments Tcm compartmentalization into LNs during their homing.

22 November 2019 in Journal of Proteome Research
Verified
Journal Article
Closed access
JAJuhani Aakko
Juhani Aakko
SPSami Pietilä
Sami Pietilä
TSTomi Suomi
Tomi Suomi
MMMehrad Mahmoudian
Mehrad Mahmoudian
RTRaine Toivonen
Raine Toivonen
LELaura L. Elo
Laura L. Elo